Kantonsspital St.Gallen
login

Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis

Alexander A Navarini, Petr Hruz, Christoph T Berger, Tie Zheng Hou, Charlotte Schwab, Annemarie Gabrysch, Rebecca Higgins, Natalie Frede, Sgier Padberg, Olle Kämpe, Anne-Valérie Burgener, Florian Marquardsen, Fabian Baldin, Marc Bigler, Anne Kistner, Annaise Jauch, Olivier Bignucolo, Benedikt Meyer, Fabian Meienberg, Matthias Mehling, Lukas T Jeker, Ingmar Heijnen, Thomas D Daikeler, Jan-Olaf Gebbers, Bodo Grimbacher, David M Sansom, Raphael Jeker, Christoph Hess & Mike Recher

citation Navarini A A, Hruz P, Berger C T, Hou T Z, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg S, Kämpe O, Burgener A V, Marquardsen F, Baldin F, Bigler M, Kistner A, Jauch A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker L T, Heijnen I, Daikeler T D, Gebbers J O, Grimbacher B, Sansom D M, Jeker R, Hess C, Recher M. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. J Allergy Clin Immunol 2016; 139:1043-1046.e5.
   
type journal paper/review (English)
date of publishing 28-11-2016
journal title J Allergy Clin Immunol (139/3)
ISSN electronic 1097-6825
pages 1043-1046.e5
PubMed 27908448
DOI 10.1016/j.jaci.2016.08.042